Max Costa

879 total citations
25 papers, 735 citations indexed

About

Max Costa is a scholar working on Molecular Biology, Biochemistry and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Max Costa has authored 25 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Biochemistry and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Max Costa's work include Polyamine Metabolism and Applications (10 papers), Amino Acid Enzymes and Metabolism (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Max Costa is often cited by papers focused on Polyamine Metabolism and Applications (10 papers), Amino Acid Enzymes and Metabolism (9 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Max Costa collaborates with scholars based in United States. Max Costa's co-authors include Anatoly Zhitkovich, Victoria Voitkun, Hilton H. Mollenhauer, Diane Haddock Russell, Eugene W. Gerner, Masayasu Sugiyama, Xin Wei Wang, Carol‐Ann Manen, Diane H. Russell and Ronald M. Evans and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Biochemical Pharmacology.

In The Last Decade

Max Costa

24 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Costa United States 16 346 275 144 133 132 25 735
Michael D. Stonard United Kingdom 16 200 0.6× 286 1.0× 109 0.8× 113 0.8× 154 1.2× 28 776
Karl‐Heinz Summer Germany 20 436 1.3× 160 0.6× 235 1.6× 139 1.0× 169 1.3× 33 1.1k
Marie A. Amoruso United States 15 334 1.0× 205 0.7× 41 0.3× 175 1.3× 125 0.9× 26 858
Domizio Serra Italy 7 156 0.5× 389 1.4× 68 0.5× 158 1.2× 121 0.9× 7 689
M.D. Reuber United States 17 350 1.0× 287 1.0× 176 1.2× 334 2.5× 36 0.3× 62 1.0k
Timothy W. Robison United States 17 364 1.1× 98 0.4× 189 1.3× 165 1.2× 47 0.4× 47 798
Karen L. Pennington United States 19 430 1.2× 221 0.8× 37 0.3× 126 0.9× 82 0.6× 59 1.1k
Victoria Wong United States 15 379 1.1× 236 0.9× 36 0.3× 169 1.3× 56 0.4× 23 1.0k
J.G. Evans United Kingdom 19 453 1.3× 166 0.6× 77 0.5× 297 2.2× 62 0.5× 54 1.1k
Nadia Gorman United States 20 751 2.2× 118 0.4× 33 0.2× 82 0.6× 64 0.5× 44 1.1k

Countries citing papers authored by Max Costa

Since Specialization
Citations

This map shows the geographic impact of Max Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Costa more than expected).

Fields of papers citing papers by Max Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Costa. The network helps show where Max Costa may publish in the future.

Co-authorship network of co-authors of Max Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Max Costa. A scholar is included among the top collaborators of Max Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Costa. Max Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Qingshan, Xiaomei Li, Roy E. Shore, et al.. (2005). Proteomics and Cr(VI) exposure: exploring new biomarkers in humans. Cancer Research. 65. 518–519. 1 indexed citations
2.
Zhitkovich, Anatoly, Victoria Voitkun, & Max Costa. (1995). Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis. 16(4). 907–913. 109 indexed citations
3.
Huang, Xi, Catherine B. Klein, & Max Costa. (1994). Crystalline Ni3S2 specifically enhances the formation of oxidants in the nuclei of CHO cells as detected by dichlorofluorescein. Carcinogenesis. 15(3). 545–548. 38 indexed citations
4.
Sugiyama, Masayasu, Xin Wei Wang, & Max Costa. (1986). Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines.. PubMed. 46(9). 4547–51. 74 indexed citations
5.
Costa, Max. (1984). Approaches toward studying genotoxicity and potential carcinogenicity of metal compounds in vitro.. PubMed. 37(6). 231–7. 3 indexed citations
6.
Costa, Max, et al.. (1982). Ornithine decarboxylase and polyamine levels are reduced in CHO cells deficient in cAMP-dependent protein kinase. Biochemical and Biophysical Research Communications. 107(1). 109–116. 6 indexed citations
7.
Abbracchio, Maria P., J. Daniel Heck, & Max Costa. (1982). The phagocytosis and transforming activity of crystalline metal sulfide particles are related to their negative surface charge. Carcinogenesis. 3(2). 175–180. 54 indexed citations
8.
Evans, Ronald M., Peter J. Davies, & Max Costa. (1982). Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian cells.. PubMed. 42(7). 2729–35. 66 indexed citations
9.
Abbracchio, Maria P., Marco Meloni, & Max Costa. (1981). Cellular effects of ornithine decarboxylase induction in cells maintained with a salts/glucose medium. Life Sciences. 28(8). 937–944. 2 indexed citations
10.
Meloni, Marco, et al.. (1980). The differential activation of ornithine decarboxylase in synchronized cultures maintained with a salts/glucose medium. Experimental Cell Research. 126(2). 465–469. 6 indexed citations
11.
Costa, Max, et al.. (1980). Regulation of ornithine decarboxylase activity by amino acids, cyclic AMP and luteinizing hormone in cultured mammalian cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 608(2). 398–408. 19 indexed citations
12.
Costa, Max. (1980). Metal Carcinogenesis Testing. Humana Press eBooks. 13 indexed citations
13.
14.
Manen, Carol‐Ann, Max Costa, I.G. Sipes, & Diane Haddock Russell. (1978). Further evidence of cyclic amp-mediated hypertrophy as a prerequisite of drug-specific enzyme induction. Biochemical Pharmacology. 27(2). 219–224. 27 indexed citations
15.
Costa, Max, et al.. (1978). Calcium, asparagine and cAMP are required for ornithine decarboxylase activation in intact Chinese hamster ovary cells. Biochemical and Biophysical Research Communications. 85(3). 1156–1164. 42 indexed citations
16.
Costa, Max. (1978). Superinduction of ornithine decarboxylase by Actinomycin D and Cordycepin. Biochemical and Biophysical Research Communications. 81(3). 832–840. 15 indexed citations
17.
Costa, Max, Eugene W. Gerner, & Diane Haddock Russell. (1978). Cyclic AMP levels and types I and II cyclic AMP-dependent protein kinase activity in synchronized cells and in quiescent cultures stimulated to proliferate. Biochimica et Biophysica Acta (BBA) - General Subjects. 538(1). 1–10. 41 indexed citations
18.
Costa, Max. (1977). Endogenous protein kinase inhibitor levels regulate changes in specific activity of protein kinase in quiescent cells stimulated to proliferate. Biochemical and Biophysical Research Communications. 78(4). 1311–1318. 24 indexed citations
20.
Costa, Max, Eugene W. Gerner, & Diane H. Russell. (1976). G1 specific increases in cyclic AMP levels and protein kinase activity in Chinese hamster ovary cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 425(2). 246–255. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026